Enshidipine, an innovative drug targeting isocitrate dehydrogenase-2 (IDH2) mutations, is indicated for adult patients with relapsed or refractory acute myeloid leukemia (AML) and was approved by the US FDA in 2017. This drug is not yet approved in China and is therefore not included in the national medical insurance catalog. Enshidipine manufactured by Luxius Pharmaceutical in Laos, in a specification of 50mg*30 tablets/box, has a market reference price of approximately US$170.
What is the market price of Enshidipine?
The price of Enshidipine is influenced by various factors, such as differences in pharmaceutical manufacturers, sales regions, and supply chain management. Currently, the main manufacturers of Enshidipine on the market are Luxius Pharmaceutical in Laos and Everest Pharmaceutical in Bangladesh.
Price Trends
The latest market reference price for Enshidipine manufactured by Luxius Pharmaceutical in Laos, in a specification of 50mg*30 tablets, is approximately US$170 per box; while the reference price for the same specification and product manufactured by Everest Pharmaceutical in Bangladesh is approximately US$482 per box. The prices mentioned above are for reference only. Patients should consider their own financial situation, their attending physician's advice, and the reliability of the drug's source when making a purchase decision.
Price Fluctuation Trends
The price of emcidipine is not fixed and fluctuates due to multiple factors, including global market dynamics, raw material procurement costs, exchange rate fluctuations, and relevant policy adjustments. In recent years, with the continuous expansion of the generic drug market and intensified industry competition, the price of emcidipine has shown a certain downward trend. Patients still need to closely monitor market changes to make a purchase decision at the appropriate time.
Emcidipine Purchase Channels
For patients who need to purchase emcidipine, having reliable purchase channels is crucial. The following are some recommended purchase channels:
Regulated Medical Institutions
Hospitals and reputable pharmacies are the primary choices for purchasing emcidipine. These institutions usually have established stable cooperative relationships with pharmaceutical manufacturers, ensuring traceability and greater assurance of drug sources. Patients can also obtain professional medication guidance and consultation services at hospitals or pharmacies.
International Drug Procurement Platforms
With the acceleration of globalization, international drug procurement platforms have gradually become an important channel for patients to obtain high-quality overseas drugs. These platforms typically possess abundant drug resources and professional procurement teams, providing patients with convenient and efficient medication purchasing services.
Enshidipine Storage Methods
Proper storage is crucial for ensuring the safe use of enshidipine. The following are specific storage recommendations:
Temperature Control
Enshidipine should be stored at 20–25ºC, with an allowable temperature fluctuation range of 15–30ºC. Excessively high or low temperatures may affect the stability of the drug and reduce its efficacy. Patients should store the medication in a cool, dark place indoors, avoiding direct sunlight and extreme temperature changes. For further questions, please click for free online consultation.
Moisture and Humidity Protection
Changes in humidity may adversely affect the stability of enshidipine. Patients should store the medication in a dry, well-ventilated area to prevent moisture absorption.
Light Protection
Light exposure may negatively affect the stability of enshidipine. Patients should store the medication in a dark location or in an opaque container to prevent light exposure.
